Groww Logo
Home>IPO>Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic IPO

Vijaya Diagnostic Centre Ltd.

₹14,616 /28 sharesMinimum Investment

Vijaya Diagnostic IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
1 Sep ‘21 - 3 Sep ‘21₹14,61628₹522 - ₹531
Issue SizeIPO Doc
1895.04Cr
RHP PDF

Subscription Status As on 03 Sep '21, 5:00 PM

  • Retail Individual Investor
    1.09x
  • Non-Institutional Investor
    1.32x
  • Qualified Institutional Buyers
    13.07x
  • Employees
    0.98x

About Vijaya Diagnostic

Vijaya Diagnostic Centre Limited is the largest integrated diagnostic chain in southern India, by operating revenue, and
Founded
2002
Managing Director
K Sunil Chandra
Vijaya Diagnostic IPO Review, Date, Price, Details - Upcoming IPO 2021

Strengths & Risks

  • Largest and fastest-growing diagnostic chain with a dominant position in south India according to a CRISIL report.
  • Well-positioned to leverage the high growth in the Indian diagnostics industry.
  • Integrated diagnostics provider that offers a one-stop solution at an affordable price with a focus on superior quality standards.
  • High brand recall driving high individual consumer business share and customer stickiness.
  • Strong technical capabilities, quality infrastructure, and state of the art medical technology with strong IT infrastructure.
  • Dedicated management team with significant industry experience.
  • Business and prospects may be adversely affected if it is unable to maintain and grow its brand name and brand image..
  • Impact of global health epidemics, including the recent COVID-19 outbreak.
  • Any interruptions at its flagship center and other diagnostic centers that may affect its ability to process diagnostic tests.
  • Geographic concentration of its operations in South India.
  • Outstanding legal proceedings involving the company, subsidiaries, and directors.
  • Losses incurred by its group companies in the past.
  • Any failure by third parties in providing testing equipment and reagents as required.
  • Any failure or malfunction of the equipment.
  • Non-compliance with and changes in any of the applicable laws, rules, or regulations, including pricing, safety, health, and environmental laws.
  • Requirement of certain approvals, licenses, registrations, and permits for conducting its business and our inability to obtain, retain or renew them in a timely manner.
  • A highly competitive business environment.

Financials

*All values are in Rs. Cr
No Graph Data To Display
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.2.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

ABOUT GROWW